Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact

Citations to this article

Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians
Farsad Afshinnia, … , Matthias Kretzler, Subramaniam Pennathur
Farsad Afshinnia, … , Matthias Kretzler, Subramaniam Pennathur
Published October 1, 2019
Citation Information: JCI Insight. 2019;4(21):e130317. https://doi.org/10.1172/jci.insight.130317.
View: Text | PDF
Clinical Research and Public Health Metabolism Nephrology

Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians

  • Text
  • PDF
Abstract

BACKGROUND In this study, we identified the lipidomic predictors of early type 2 diabetic kidney disease (DKD) progression, which are currently undefined.METHODS This longitudinal study included 92 American Indians with type 2 diabetes. Serum lipids (406 from 18 classes) were quantified using mass spectrometry from baseline samples when iothalamate-based glomerular filtration rate (GFR) was at least 90 mL/min. Affymetrix GeneChip Array was used to measure renal transcript expression. DKD progression was defined as at least 40% decline in GFR during follow-up.RESULTS Participants had a mean age of 45 ± 9 years and median urine albumin/creatinine ratio of 43 (interquartile range 11–144). The 32 progressors had significantly higher relative abundance of polyunsaturated triacylglycerols (TAGs) and a lower abundance of C16–C20 acylcarnitines (ACs) (P < 0.001). In a Cox regression model, the main effect terms of unsaturated free fatty acids and phosphatidylethanolamines and the interaction terms of C16–C20 ACs and short-low-double-bond TAGs by categories of albuminuria independently predicted DKD progression. Renal expression of acetyl-CoA carboxylase–encoding gene (ACACA) correlated with serum diacylglycerols in the glomerular compartment (r = 0.36, and P = 0.006) and with low-double-bond TAGs in the tubulointerstitial compartment (r = 0.52, and P < 0.001).CONCLUSION Collectively, the findings reveal a previously unrecognized link between lipid markers of impaired mitochondrial β-oxidation and enhanced lipogenesis and DKD progression in individuals with preserved GFR. Renal acetyl-CoA carboxylase activation accompanies these lipidomic changes and suggests that it may be the underlying mechanism linking lipid abnormalities to DKD progression.TRIAL REGISTRATION ClinicalTrials.gov, NCT00340678.FUNDING NIH R24DK082841, K08DK106523, R03DK121941, P30DK089503, P30DK081943, and P30DK020572.

Authors

Farsad Afshinnia, Viji Nair, Jiahe Lin, Thekkelnaycke M. Rajendiran, Tanu Soni, Jaeman Byun, Kumar Sharma, Patrice E. Fort, Thomas W. Gardner, Helen C. Looker, Robert G. Nelson, Frank C. Brosius, Eva L. Feldman, George Michailidis, Matthias Kretzler, Subramaniam Pennathur

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2009 Total
Citations: 9 15 15 13 17 5 1 1 76
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (76)

Title and authors Publication Year
Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease
Guo X, Zhang Z, Li C, Li X, Cao Y, Wang Y, Li J, Wang Y, Wang K, Liu Y, Xie C, Zhong Y
Metabolism Open 2025
Metabolomics for the Identification of Biomarkers in Kidney Diseases
Pandey S
Nanotheranostics 2025
Progress and perspectives of metabolic biomarkers in blood sample for diabetic microvascular complications.
Yan L, Wang X, Xiang Y, Ru S, Fang C, Wu X
Metabolomics : Official journal of the Metabolomic Society 2025
Targeting lipid metabolic reprogramming to alleviate diabetic kidney disease: molecular insights and therapeutic strategies
Yu W, Haoyu Y, Ling Z, Xing H, Pengfei X, Anzhu W, Lili Z, Linhua Z
Frontiers in Immunology 2025
Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study
Su J, Hu J, Liu H, Guo Y, Shi Y, Zheng Y, Dong Z, Liu J, Xu Z, Yu X, Mei J, Peng J, Wang L, Liu Q
Diabetology & Metabolic Syndrome 2025
P16-positive senescent cells promote DKD by the dysregulation of glycolysis and mitochondrial metabolism
Lu X, Wu J, Agborbesong E, Li X
Cell Death Discovery 2025
Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.
Hao Y, She X, Huang G, Chu X, Zhao S, Lv Z, Tao J, Zhang Y
BMC ophthalmology 2025
DHA–Triacylglycerol Accumulation in Tacrolimus-Induced Nephrotoxicity Identified by Lipidomic Profiling
Nishida S, Ishima T, Iwami D, Nagai R, Aizawa K
International Journal of Molecular Sciences 2025
Diabetic retinal disease.
Sivaprasad S, Wong TY, Gardner TW, Sun JK, Bressler NM
Nature reviews. Disease primers 2025
Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease
Wang MY, Zhang Z, Zhao S, Onodera T, Sun X, Zhu Q, Li C, Li N, Chen S, Paredes M, Gautron L, Charron MJ, Marciano DK, Gordillo R, Drucker DJ, Scherer PE
Cell Metabolism 2024
Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease
Natale P, Palmer SC, Navaneethan SD, Craig JC, Strippoli GF
The Cochrane Database of Systematic Reviews 2024
Molecular mechanism of renal lipid accumulation in diabetic kidney disease
Fang Z, Liu R, Xie J, He JC
Journal of Cellular and Molecular Medicine 2024
The key role of altered tubule cell lipid metabolism in kidney disease development
Lee LE, Doke T, Mukhi D, Susztak K
Kidney International 2024
Sodium–Glucose Cotransporter Inhibitors: Cellular Mechanisms Involved in the Lipid Metabolism and the Treatment of Chronic Kidney Disease Associated with Metabolic Syndrome
Cortés-Camacho F, Zambrano-Vásquez OR, Aréchaga-Ocampo E, Castañeda-Sánchez JI, Gonzaga-Sánchez JG, Sánchez-Gloria JL, Sánchez-Lozada LG, Osorio-Alonso H
Antioxidants 2024
Voclosporin Induces Systemic Lipidomic Alterations: Implications for Lupus Nephritis Remission
Afshinnia F, Rajendiran TM, Byun J, Arnipalli MS, Rehaume LM, Cross JL, Huizinga RB, Pennathur S
Kidney International Reports 2024
Identification of spatial specific lipid metabolic signatures in long-standing diabetic kidney disease
Yiran Zhang, Hai-long Piao, Di Chen
Metabolites 2024
Insulin Resistance, Obesity, and Lipotoxicity.
Yazıcı D, Demir SÇ, Sezer H
Advances in experimental medicine and biology 2024
Attenuated kidney oxidative metabolism in young adults with type 1 diabetes
Ye Ji Choi, Gabriel Richard, Guanshi Zhang, Jeffrey B Hodgin, Dawit Demeke, Yingbao Yang, Jennifer A. Schaub, Ian M. Tamayo, Bhupendra K Gurung, Abhijit S Naik, Viji Nair, Carissa Birznieks, Alexis MacDonald, Phoom Narongkiatikhun, Susan Gross, Lynette Driscoll, Maureen Flynn, Kalie Tommerdahl, Kristen J Nadeau, Viral N Shah, Tim Vigers, Janet Snell-Bergeon, Jessica Kendrick, Daniel H. van Raalte, Lu-Ping Li, Pottumarthi Prasad, Patricia Ladd, Bennett B Chin, David Z.I. Cherney, Phillip J. McCown, Fadhl Alakwaa, Edgar A. Otto, Frank Brosius, Pierre Jean Saulnier, Victor G. Puelles, Jesse A. Goodrich, Kelly Street, Manjeri A. Venkatachalam, Aaron Ruiz, Ian H. de Boer, Robert G. Nelson, Laura Pyle, Denis Blondin, Kumar Sharma, Matthias Kretzler, Petter Bjornstad
Journal of Clinical Investigation 2024
Metabolic Chaos in Kidney Disease: Unraveling Energy Dysregulation
Gupta P, Zhu S, Gui Y, Zhou D
Journal of Clinical Medicine 2024
Unraveling Diabetic Kidney Disease: The Roles of Mitochondrial Dysfunction and Immunometabolism
Narongkiatikhun P, Choi YJ, Hampson H, Gotzamanis J, Zhang G, van Raalte DH, de Boer IH, Nelson RG, Tommerdahl KL, McCown PJ, Kanter J, Sharma K, Bjornstad P, Saulnier PJ
Kidney International Reports 2024
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Hill C, McKnight AJ, Smyth LJ
Diabetic Medicine 2024
Metabolomic and Lipidomic Profiling for Pre-Transplant Assessment of Delayed Graft Function Risk Using Chemical Biopsy with Microextraction Probes
Warmuzińska N, Łuczykowski K, Stryjak I, Wojtal E, Woderska-Jasińska A, Masztalerz M, Włodarczyk Z, Bojko B
International Journal of Molecular Sciences 2024
Crosstalk between glomeruli and tubules.
Fogo AB, Harris RC
Nature reviews. Nephrology 2024
Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function decline.
Chen Y, Torta F, Koh HWL, Benke PI, Gurung RL, Liu JJ, Ang K, Shao YM, Chan GC, Choo JC, Ching J, Kovalik JP, Kalhan T, Dorajoo R, Khor CC, Li Y, Tang WE, Seah DEJ, Sabanayagam C, Sobota RM, Venkataraman K, Coffman T, Wenk MR, Sim X, Lim SC, Tai ES
Diabetologia 2024
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth onset type 2 diabetes
Jennifer Schaub, Fadhl AlAkwaa, Phillip J. McCown, Abhijit Naik, Viji Nair, Sean Eddy, Rajasree Menon, Edgar Otto, Dawit Demeke, John Hartman, Damian Fermin, Christopher O'Connor, Lalita Subramanian, Markus Bitzer, Roger Harned, Patricia Ladd, Meda Pavkov, Laura Pyle, Subramaniam Pennathur, Ken Inoki, Jeffrey Hodgin, Frank III, Robert Nelson, Matthias Kretzler, Petter Bjornstad
Journal of Clinical Investigation 2023
Molecular mechanisms of diabetic kidney disease
Samer Mohandes, Tomohito Doke, Hailong Hu, Dhanunjay Mukhi, Poonam Dhillon and Katalin Susztak
Journal of Clinical Investigation 2023
Metabolic differences in diabetic kidney disease patients with and without moderately increased albuminuria
Stein Hallan, Marius A Øvrehus, Manjula Darshi, Daniel Montemayor, Knut A Langlo, Per Bruheim, Kumar Sharma
Kidney360 2023
Unilateral Nephrectomized SHR/NDmcr-cp Rat Shows a Progressive Decline of Glomerular Filtration With Tubular Interstitial Lesions
SHINOZAKI Y, FUKUI K, MAEKAWA M, TOYODA K, YOSHIUCHI H, INAGAKI K, UNO K, MIYAJIMA K, OHTA T
2023
The role of exercise in improving hyperlipidemia-renal injuries induced by a high-fat diet: a literature review
Chen JS, Xie PF, Feng H
PeerJ 2023
The association and prediction value of acylcarnitine on diabetic nephropathy in Chinese patients with type 2 diabetes mellitus
Li X, Miao Y, Fang Z, Zhang Q
Diabetology & metabolic syndrome 2023
The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease
Li L, Long J, Mise K, Poungavrin N, Lorenzi PL, Mahmud I, Tan L, Saha PK, Kanwar YS, Chang BH, Danesh FR
The Journal of biological chemistry 2023
Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes
Trischitta V, Mastroianno M, Scarale MG, Prehn C, Salvemini L, Fontana A, Adamski J, Schena FP, Cosmo SD, Copetti M, Menzaghi C
BMJ Open Diabetes Research & Care 2023
Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications
Hammad SM, Lopes-Virella MF
International journal of molecular sciences 2023
Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease
Dai ZC, Chen JX, Zou R, Liang XB, Tang JX, Yao CW
Frontiers in immunology 2023
Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization
Onodera T, Wang MY, Rutkowski JM, Deja S, Chen S, Balzer MS, Kim DS, Sun X, An YA, Field BC, Lee C, Matsuo EI, Mizerska M, Sanjana I, Fujiwara N, Kusminski CM, Gordillo R, Gautron L, Marciano DK, Hu MC, Burgess SC, Susztak K, Moe OW, Scherer PE
Nature Communications 2023
Plasma Citrate Levels Are Associated with an Increased Risk of Cardiovascular Mortality in Patients with Type 2 Diabetes (Zodiac-64)
Bourgonje AR, Connelly MA, van Goor H, van Dijk PR, Dullaart RP
Journal of Clinical Medicine 2023
Higher circulating levels of non-esterified fatty acids are associated with faster kidney function decline in post-menopausal women with type 2 diabetes: a pilot prospective study.
Mantovani A, Csermely A, Cappelli D, Taverna A, Sani E, Shtembari E, Pagani M, Targher G
Acta Diabetologica 2023
Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia
Chae SY, Kim Y, Park CW
Antioxidants 2023
Luteolin alleviates depression‐like behavior by modulating glycerophospholipid metabolism in the hippocampus and prefrontal cortex of LOD rats
Wu X, Xu H, Zeng N, Li H, Yao G, Liu K, Yan C, Wu L
CNS Neuroscience & Therapeutics 2023
Metabolite Profiling of CKD Progression in the Chronic Renal Insufficiency Cohort (CRIC) Study
Donghai Wen, Zihe Zheng, Aditya Surapaneni, Bing Yu, Linda Zhou, Wen Zhou, Dawei Xie, Haochang Shou, Julian Pacheco, Sahir Kalim, Jiang He, Chi-yuan Hsu, Afshin Parsa, Panduranga Rao, James Sondheimer, Raymond Townsend, Sushrut Waikar, Casey Rebholz, Michelle Denburg, Paul Kimmel, Ramachandran Vasan, Clary Clish, Josef Coresh, Harold Feldman, Morgan Grams, Eugene Rhee
JCI Insight 2022
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
X Mu, M Yang, P Ling, A Wu, H Zhou, J Jiang
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2022
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease
W Martin, Y Chuah, M Abdelaal, A Pedersen, D Malmodin, S Abrahamsson, M Hutter, C Godson, E Brennan, L Fändriks, C le Roux, N Docherty
Frontiers in Endocrinology 2022
High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study
Zhang J, Fuhrer T, Ye H, Kwan B, Montemayor D, Tumova J, Darshi M, Afshinnia F, Scialla JJ, Anderson A, Porter AC, Taliercio JJ, Rincon-Choles H, Rao P, Xie D, Feldman H, Sauer U, Sharma K, Natarajan L
American Journal of Nephrology 2022
Development and Validation of a Model That Predicts the Risk of Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
Yang J, Jiang S
International journal of general medicine 2022
A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy
Rumora AE, Guo K, Hinder LM, O\u2019Brien PD, Hayes JM, Hur J, Feldman EL
Frontiers in physiology 2022
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
Afshinnia F, Reynolds EL, Rajendiran TM, Soni T, Byun J, Savelieff MG, Looker HC, Nelson RG, Michailidis G, Callaghan BC, Pennathur S, Feldman EL
Annals of Clinical and Translational Neurology 2022
The Michigan O'Brien Kidney Research Center: transforming translational kidney research through systems biology.
Bitzer M, Ju W, Subramanian L, Troost JP, Tychewicz J, Steck B, Wiggins RC, Gipson DS, Gadegbeku CA, Brosius FC 3rd, Kretzler M, Pennathur S
American journal of physiology. Renal physiology 2022
Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells.
Kayampilly P, Roeser N, Rajendiran TM, Pennathur S, Afshinnia F
Metabolites 2022
Lipid droplet - mitochondria coupling: A novel lipid metabolism regulatory hub in diabetic nephropathy
Yang M, Luo S, Yang J, Chen W, He L, Liu D, Zhao L, Wang X
Frontiers in Endocrinology 2022
Integrated analysis of comprehensive metabolomics and network pharmacology to reveal the mechanisms of abelmoschus manihot (L.) medik. in the treatment of cisplatin-induced chronic kidney disease
Liao JC, Li CY, Teng FM, Jian-Chen, Yu JY, Ju WZ, Zou JD
Frontiers in pharmacology 2022
Present and future directions in diabetic kidney disease
Limonte CP, Kretzler M, Pennathur S, Pop-Busui R, de Boer IH
Journal of Diabetes and its Complications 2022
Lipidomic profiling in the Strong Heart Study identified American Indians at risk of chronic kidney disease
Zeng W, Beyene HB, Kuokkanen M, Miao G, Magliano DJ, Umans JG, Franceschini N, Cole SA, Michailidis G, Lee ET, Howard BV, Fiehn O, Curran JE, Blangero J, Meikle PJ, Zhao J
Kidney International 2022
Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy
Patrice E. Fort, Thekkelnaycke Rajendiran, Tanu Soni, Jaeman Byun, Yang Shan, Helen Looker, Robert G Nelson, Matthias Kretzler, George Michailidis, Jerome E Roger, Thomas Gardner, Steven F. Abcouwer, Subramaniam Pennathur, Farsad Afshinnia
JCI Insight 2021
Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease
KM Sas, J Lin, CH Wang, H Zhang, J Saha, TM Rajendiran, T Soni, V Nair, F Eichinger, M Kretzler, FC Brosius, G Michailidis, S Pennathur
Metabolomics 2021
Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases
AP Jiménez-Uribe, EY Hernández-Cruz, KJ Ramírez-Magaña, J Pedraza-Chaverri
Biomolecules 2021
Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease
J Baek, C He, F Afshinnia, G Michailidis, S Pennathur
Nature Reviews Nephrology 2021
Plasma lipid metabolites associate with diabetic polyneuropathy in a cohort with type 2 diabetes
AE Rumora, K Guo, FM Alakwaa, ST Andersen, EL Reynolds, ME Jørgensen, DR Witte, H Tankisi, M Charles, MG Savelieff, BC Callaghan, TS Jensen, EL Feldman
Annals of Clinical and Translational Neurology 2021
New insights into renal lipid dysmetabolism in diabetic kidney disease
A Mitrofanova, G Burke, S Merscher, A Fornoni
World journal of diabetes 2021
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
H Noels, M Lehrke, R Vanholder, J Jankowski
Nature Reviews Nephrology 2021
Lipid Disorders in NAFLD and Chronic Kidney Disease
M Yang, CA Geng, X Liu, M Guan
Biomedicines 2021
Urinary 2-Hydroxyglutarate Enantiomers Are Markedly Elevated in a Murine Model of Type 2 Diabetic Kidney Disease
J Baek, S Pennathur
Metabolites 2021
In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease
B Linnan, W Yanzhe, Z Ling, L Yuyuan, C Sijia, X Xinmiao, L Fengqin, W Xiaoxia
Frontiers in physiology 2021
Circulating Free Fatty Acid and Phospholipid Signature Predicts Early Rapid Kidney Function Decline in Patients With Type 1 Diabetes
F Afshinnia, T Rajendiran, C He, J Byun, D Montemayor, M Darshi, J Tumova, J Kim, C Limonte, R Miller, T Costacou, T Orchard, T Ahluwalia, P Rossing, J Snell-Bergeon, I de Boer, L Natarajan, G Michailidis, K Sharma, S Pennathur
Diabetes care 2021
Perspectives in systems nephrology
MT Lindenmeyer, F Alakwaa, M Rose, M Kretzler
Cell and Tissue Research 2021
Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease
WW Pan, TW Gardner, JL Harder
Journal of Clinical Medicine 2021
TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension
A Santiago-Hernandez, M Martin-Lorenzo, A Martin-Blazquez, G Ruiz-Hurtado, MG Barderas, J Segura, LM Ruilope, G Alvarez-Llamas
Antioxidants 2021
Plasma Targeted Metabolomics Analysis for Amino Acids and Acylcarnitines in Patients with Prediabetes, Type 2 Diabetes Mellitus, and Diabetic Vascular Complications
X Li, Y Li, Y Liang, R Hu, W Xu, Y Liu
Diabetes & Metabolism Journal 2021
Metabolomics in Diabetes and Diabetic Complications: Insights from Epidemiological Studies
Q Jin, RC Ma
Cells 2021
Protocol for a preclinical systematic review and meta-analysis of pharmacological targeting of peroxisome proliferator-activated receptors in experimental renal injury
WP Martin, YH Chuah, E Conroy, AL Reynolds, C Judge, FJ López-Hernández, CW le Roux, NG Docherty
2021
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
L Opazo-Ríos, S Mas, G Marín-Royo, S Mezzano, C Gómez-Guerrero, JA Moreno, J Egido
International journal of molecular sciences 2020
A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 Diabetes
CP Limonte, E Valo, D Montemayor, F Afshinnia, TS Ahluwalia, T Costacou, M Darshi, C Forsblom, AN Hoofnagle, PH Groop, RG Miller, TJ Orchard, S Pennathur, P Rossing, N Sandholm, JK Snell-Bergeon, H Ye, J Zhang, L Natarajan, IH de Boer, K Sharma
American Journal of Nephrology 2020
Strategies to educe severe diabetic foot nfections and complications uring pidemics (STRIDE)
BM Schmidt, ME Munson, GM Rothenberg, CM Holmes, R Pop-Busui
Journal of Diabetes and its Complications 2020
Weighted gene co-expression network analysis identifies FCER1G as a key gene associated with diabetic kidney disease
S Liu, C Wang, H Yang, T Zhu, H Jiang, J Chen
Annals of translational medicine 2020
The emerging role of dyslipidemia in diabetic microvascular complications.
Savelieff MG, Callaghan BC, Feldman EL
Current opinion in endocrinology, diabetes, and obesity 2020
Lipids and Cardiovascular Risk with CKD
F Afshinnia, S Pennathur
Clinical journal of the American Society of Nephrology : CJASN 2019
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts